Akero Therapeutics, Inc.
← Back to AKRO Overview

Akero Therapeutics, Inc. (AKRO)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-11.99

Financial Fundamentals

AKROQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2017-12-31-111.17
2018-03-31-231.31
2018-06-30-11.17
2018-09-30-8.64
2018-12-31-1.58
2019-03-31-22.90
2019-06-30-17.62
2019-09-30-10.16
2019-12-31-10.09
2020-03-31-12.62
2020-06-30-10.93
2020-09-30-12.22
2020-12-31-7.50
2021-03-31-16.87
2021-06-30-7.47
2021-09-30-7.98
2021-12-31-5.69
2022-03-31-4.79
2022-06-30-3.07
2022-09-30-9.35
2022-12-31-31.14
2023-03-31-19.13
2023-06-30-19.45
2023-09-30-17.81
2023-12-31-5.90
2024-03-31-6.69
2024-06-30-7.15
2024-09-30-6.83
2024-12-31-7.03
2025-03-31-11.24
2025-06-30-15.51
2025-09-30-11.99

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.